2026-10-12T06:40:20Z https://api.figshare.com/v2/oai

oai:figshare.com:article/33776290 2026-09-15T07:42:05Z category_37339 category_37342 category_37354 category_37357 category_37366 category_37375 portal_1012 item_type_3 month_year_09_2026

Supplementary Table S8 from Epigenetic Liquid Biopsy Enables Universal Mutation-Agnostic Molecular Surveillance for High-Risk Neuroblastoma Nurit Gal-Mark (24916048) Assaf Grunwald (24916051) Valid Gahramanov (24916054) Michal Hameiri-Grossman (24916057) Elena Shinderman-Maman (24916060) Dafna Gaas (24916063) Keren Shichrur (24916066) Jacques Mordoukh (24916069) Nino Oniashvili (24916072) Eva Chausky Barzakh (24916075) Aviv Sever (24916078) Shirah Amar (24916081) Shifra Ash (22164821) Yehudit Birger (24916084) Shai Izraeli (24916087) Yuval Ebenstein (24916090) Esther R. Berko (15123364) Cancer Cancer Risk Factors Molecular and Cellular Biology Cancer Detection and Diagnosis Clinical Research and Trials Methods and Technology Biomarkers Epigenetic biomarkers Epigenetics DNA methylation Liquid Biopsy Precision Medicine <p>Supplementary Table S8: List of 188 neuroblastoma-specific DMRs identified by comparison with a normal human cell-type methylation atlas including and excluding neuronal tissues (13).</p> 2026-09-15T00:00:00Z Dataset Dataset 10.1158/1078-0432.33776290 https://figshare.com/articles/dataset/Supplementary_Table_S8_from_Epigenetic_Liquid_Biopsy_Enables_Universal_Mutation-Agnostic_Molecular_Surveillance_for_High-Risk_Neuroblastoma/33776290 CC BY